HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Francisco S Cayabyab Selected Research

batimastat (BB 94)

9/2017Neutrophil Infiltration and Matrix Metalloproteinase-9 in Lacunar Infarction.
7/2013Involvement of matrix metalloproteinases-2 and -9 in the formation of a lacuna-like cerebral cavity.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Francisco S Cayabyab Research Topics

Disease

11Atherosclerosis
12/2017 - 01/2014
5Hypoxia (Hypoxemia)
05/2021 - 11/2006
3Parkinson Disease (Parkinson's Disease)
10/2022 - 04/2017
3Stroke (Strokes)
05/2021 - 07/2014
3Neoplasms (Cancer)
01/2020 - 04/2002
3Epilepsy (Aura)
01/2020 - 01/2002
3Ischemia
07/2014 - 11/2010
2Reperfusion Injury
05/2021 - 03/2016
2Inflammation (Inflammations)
11/2014 - 01/2014
1Synucleinopathies
10/2022
1Neurodegenerative Diseases (Neurodegenerative Disease)
04/2020
1Cardiotoxicity
01/2020
1Hyperlipidemias (Hyperlipidemia)
12/2017
1Non-alcoholic Fatty Liver Disease
12/2017
1Type 2 Diabetes Mellitus (MODY)
12/2017
1Insulin Resistance
12/2017
1Lacunar Stroke
09/2017
1Brain Ischemia (Cerebral Ischemia)
03/2016
1Brain Hypoxia (Cerebral Hypoxia)
07/2014
1Cardiovascular Diseases (Cardiovascular Disease)
01/2014
1Sitosterolemia
01/2014
1Cysts
07/2013
1Protein-Energy Malnutrition (Marasmus)
11/2010
1Psychotic Disorders (Schizoaffective Disorder)
01/2002
1Nervous System Diseases (Neurological Disorders)
01/2002

Drug/Important Bio-Agent (IBA)

7CholesterolIBA
12/2017 - 01/2014
4Adenosine A1 ReceptorIBA
10/2022 - 07/2014
4Adenosine (Adenocard)FDA LinkGeneric
05/2021 - 11/2006
4Proteins (Proteins, Gene)FDA Link
01/2020 - 11/2010
2Peptides (Polypeptides)IBA
05/2021 - 07/2014
2sortilinIBA
12/2017 - 09/2016
2LipidsIBA
12/2017 - 01/2014
2batimastat (BB 94)IBA
09/2017 - 07/2013
2AMPA Receptors (AMPA Receptor)IBA
03/2016 - 07/2014
2ApolipoproteinsIBA
01/2016 - 01/2014
2Apolipoproteins E (ApoE)IBA
01/2016 - 01/2014
2ATP-Binding Cassette Transporters (ABC Transporters)IBA
05/2015 - 09/2014
1LigandsIBA
10/2022
1SynucleinsIBA
10/2022
1CalciumIBA
05/2021
1Dynamins (Dynamin)IBA
05/2021
1Propidium (Propidium Iodide)IBA
05/2021
1perampanelIBA
05/2021
1ParaffinIBA
01/2020
1Transcription Factors (Transcription Factor)IBA
01/2020
1Biomarkers (Surrogate Marker)IBA
01/2020
1Pharmaceutical PreparationsIBA
01/2020
1Formaldehyde (Formol)FDA Link
01/2020
1Ion Channels (Ion Channel)IBA
01/2020
1Nerve Growth Factors (Neurotrophins)IBA
09/2019
1Heme (Haem)IBA
09/2019
1Proteasome Endopeptidase Complex (Proteasome)IBA
12/2017
1VLDL LipoproteinsIBA
12/2017
1ilomastatIBA
09/2017
1N- (2(R)- 2- (hydroxamidocarbonylmethyl)- 4- methylpentanoyl)- L- tryptophan methylamideIBA
09/2017
1marimastatIBA
09/2017
1BB 1101IBA
09/2017
1Matrix Metalloproteinase 9 (Gelatinase B)IBA
09/2017
1Neuroprotective AgentsIBA
04/2017
1LDL CholesterolIBA
09/2016
1oxidized low density lipoproteinIBA
09/2016
1Phosphoprotein Phosphatases (Phosphatases, Protein)IBA
03/2016
1Histone MethyltransferasesIBA
01/2016
1DiosgeninIBA
05/2015
1Nitric Oxide (Nitrogen Monoxide)FDA Link
11/2014
1GasotransmittersIBA
11/2014
1Carbon MonoxideIBA
11/2014
13' Untranslated Regions (3' UTR)IBA
09/2014
1salicylhydroxamic acid (SHAM)IBA
07/2014
11,3-dipropyl-8-cyclopentylxanthineIBA
07/2014
1p38 Mitogen-Activated Protein KinasesIBA
07/2014
1ClathrinIBA
07/2014
1EnzymesIBA
06/2014
1Contractile ProteinsIBA
06/2014
1Interleukin-17 (Interleukin 17)IBA
04/2014
1Lipoproteins (Lipoprotein)IBA
04/2014
1Growth Differentiation Factor 15IBA
02/2014
1Phytosterols (Plant Sterols)IBA
01/2014
1CytokinesIBA
01/2014
1AntagomirsIBA
01/2014
1Minocycline (Cyclops)FDA LinkGeneric
07/2013
1Matrix Metalloproteinases (MMPs)IBA
07/2013
1Brain-Derived Neurotrophic Factor (BDNF)IBA
11/2010
1Messenger RNA (mRNA)IBA
11/2010
1pyrazolanthroneIBA
12/2007
1N(6)-cyclopentyladenosineIBA
12/2007
1Ether (Diethyl Ether)IBA
04/2002
1Antipsychotic Agents (Antipsychotics)IBA
01/2002
1T-Type Calcium Channels (T-Type Calcium Channel)IBA
01/2002
1Dopamine Receptors (Dopamine Receptor)IBA
01/2002

Therapy/Procedure

2Therapeutics
10/2022 - 05/2021